Back
Trimboli_2022_Spri_endocrine_2
Journal article

Operation rate and cancer prevalence among thyroid nodules with FNAC report of suspicious for malignancy (TIR4) or malignant (TIR5) according to Italian classification system : a systematic review and meta-analysis

  • Trimboli, Pierpaolo ORCID Servizio di Endocrinologia e Diabetologia, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland - Faculty of Biomedical Sciences, Università della Svizzera italiana, Switzerland
  • Ferrarazzo, Giulia Medicina Nucleare, Ospedale Villa Scassi Hospital, Genoa, Italy
  • Piccardo, Arnoldo ORCID Struttura Complessa di Medicina Nucleare, E.O. Ospedali Galliera, Genoa, Italy
  • Lucchini, Barbara Servizio di Endocrinologia e Diabetologia, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland - Faculty of Biomedical Sciences, Università della Svizzera italiana, Switzerland
  • Durante, Cosimo ORCID Department of Translational and Precision Medicine, “Sapienza” University of Rome, Rome, Italy
Show more…
  • 2022
Published in:
  • Endocrine. - 2022, vol. 78, p. 24–31
Thyroid
Fine-needle aspiration (FNA)
Nodules
Carcinoma
Risk of malignancy
English Background: In the Italian system for reporting thyroid cytology (ICCRTC), nodules suspicious for (TIR4) and consistent with (TIR5) malignancy are thought being 5% and 4–8% of all biopsies and having risk of malignancy of 60–80% and >95%, respectively. However, no evidence-based data exist about these figures. The present systematic review aimed at achieving solid estimates about TIR4 and TIR5 also considering potential influencing factors. Methods: The review was conducted according to MOOSE. Databases of Google Scholar and Cochrane were searched. No language restriction was used. The last search was performed on February 26th 2022. Quality assessment was performed. Proportion meta-analyses were performed using random-effect model. Statistical analyses were performed using OpenMeta [Analyst]. Results: The online search retrieved 271 articles and 16 were finally included for quantitative analysis. The risk of bias was generally low. The pooled cancer prevalence in TIR4 was 92.5% (95%CI 89.4–95.6%) with unexplained moderate heterogeneity. The pooled cancer rate among TIR5 was 99.7% (95%CI 99.3–100%) without heterogeneity. The resection rate in TIR4 and TIR5 showed heterogeneity, being the latter explained when using their prevalence among biopsies: the higher the prevalence, the higher the operation rate. The pooled risk difference between TIR5 and TIR4 was significant (OR 11.153).
Collections
Language
  • English
Classification
Medicine
License
CC BY
Open access status
hybrid
Identifiers
Persistent URL
https://n2t.net/ark:/12658/srd1326725
Statistics
Document views: 23 File downloads:
  • Trimboli_2022_Spri_endocrine_2.pdf: 89